Results 191 to 200 of about 2,846,456 (294)

95 Oral misoprostol or vaginal dinoprostone for labor induction? A randomized controlled trial

open access: bronze, 2001
Patrick Dällenbach   +3 more
openalex   +1 more source

scCompass: An Integrated Multi‐Species scRNA‐seq Database for AI‐Ready

open access: yesAdvanced Science, EarlyView.
scCompass integrates and standardizes transcriptomic data from ≈105 million single cells across 13 species, enabling the identification of stable expression genes and organ‐specific expression genes in humans and mice. It provides scalable datasets for AI model training, pretrained model checkpoints, and user‐friendly platforms for data sharing ...
Pengfei Wang   +29 more
wiley   +1 more source

440 Lower dose vaginal and oral misoprostol in labor induction—RCT

open access: bronze, 2001
David C. Young   +3 more
openalex   +1 more source

FABP4 as a Mediator of Lipid Metabolism and Pregnant Uterine Dysfunction in Obesity

open access: yesAdvanced Science, EarlyView.
Obesity during late pregnancy contributes to uterine smooth muscle dysfunction, but the underlying mechanisms are unclear. This study identifies fatty acid binding protein 4 (FABP4) as a key player in the process, mediating excessive fatty acid uptake, lipid accumulation, and mitochondrial dysfunction in myometrial cells. FABP4 could be a novel uterine
Xuan Li   +11 more
wiley   +1 more source

437 Oral misoprostol labor induction in patients with a favorable cervix

open access: bronze, 2001
Tina Delaney   +4 more
openalex   +1 more source

Sortilin‐Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA‐Encoded Lysosome‐Targeting Chimera

open access: yesAdvanced Science, EarlyView.
The study identified sortilin as a promising LTR, enabling targeted degradation of oncogenic proteins through an mRNA‐encoded MedTAC strategy. In a mouse model, MedTACPTK7 reduced PTK7 by up to 80%, extended survival, and showed excellent pharmacokinetics without toxicity, providing a scalable platform for targeted therapies.
Xin Chang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy